tickrz reports
PerkinElmer Inc (PKI)
Healthcare | Health Services
78.90  1.64%
PKI vs HEALTH SERVICES SECTOR & S&P 500
VALUATION
PKISECTORS&P 500
P/E RATIO21.9732.921.12
EV/EBITDA RATIO21.2118.312.66
P/S RATIO4.013.92.25
P/B RATIO3.455.83.45
QUALITY
RETURN ON EQUITY17.07%14.19%13.64%
RETURN ON CAPITAL8.82%20.57%10.09%
NET MARGIN10.2%8.82%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.35%
PAYOUT RATIO7.71%
3 YR DIVIDEND GROWTH0%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
7 OUT OF 9
DEBT-TO-EQUITY44%
INTEREST COVERAGE7.9x
CURRENT RATIO2.59
GROWTH
5 YR EPS GROWTH190.15%
5 YR SPS GROWTH1.94%
5 YR BPS GROWTH3.38%
About tickrz
Key Concepts
Great Investors
PerkinElmer Inc has carved out a durable competitive advantage within its industry
TICKRZBOT SUMMARY
PerkinElmer Inc receives a B ranking in our multi-factor model that blends valuation, moat, operational performance, and financial strength. View the tickrz MFM Screener here. Here's a summary of PerkinElmer Inc's factor rankings that are combined together to calculate the tickrz MFM ranking:

FACTOR RANKINGSFACTOR SCREENER 
TICKRZ MFM RANK B / 116PURE VALUE RANKC / 309
DIVIDEND RANKA / 10MOAT RANKA / 44
FINANCIAL STRENGTH RANKA / 26GROWTH RANKB / 168
MOMENTUM RANKA / 99
GURU ANALYSIS
Buffett Rank B / 166Peter Lynch Rank A / 18
PerkinElmer Inc ranks 166 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a average score, meaning it ranks in the middle of the pack on valuation, moat, volatility, and financial strength factors. The stock's average Buffett rank suggests waiting for improved valuation or quality metrics before taking action. The company's moat is strong so it could be worth investigating in the future should its valuation improve.Our Peter Lynch mutli-factor model ranks stocks on their PEG ratio, Financial Strength, margin profile, and their P/Es relative to their respective industry groups. PerkinElmer Inc ranks 18, a relatively strong ranking. Of note is PerkinElmer Inc's PEG ratio of 0.12x places it in the top 25% of S&P 500 stocks.
Alex Roepers Rank B / 202Joel Greenblatt Rank D / 366
Alex Roepers, founder of Atlantic Investment Management, looks for stocks trading at low EV/EBITDA multiples with strong and consistent free cash flow. PerkinElmer Inc ranks 202 out of the S&P 500 constituents on our Roepers-inspired multi-factor model.In his best-selling The Little Book that Beats the Market, Greenblatt introduced the Magic Formula, a straightforward approach that ranks stocks on earnings yield and return on invested capital. PerkinElmer Inc places 366 out the S&P 500 consitituents on this ranking methodology.
FACTOR RANKINGS
Value
Pure Value Ranking C / 309
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. PerkinElmer Inc's valuation score is comprised of a P/E ratio of 22x, a P/B ratio of 3.5x, a P/S ratio of 4x, and an EV/EBITDA ratio of 21.2x. PerkinElmer Inc ranks 309 out of the S&P 500 constituents on valuation--a relatively weak score.

Quality
Moat A / 44Financial Strength A / 26
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is strong. PerkinElmer Inc appears to have a durable competitive advantage within the Healthcare sector. PerkinElmer Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 7.9x, a debt/equity ratio of 44% and a Moat Rank of 44 translate to a strong Financial Strength score.


Momentum A / 99
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 34.29% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 99. PerkinElmer Inc's strong 12 month stock performance will appeal to momentum investors.

Yield A / 10
Value + Yield
Shares currently yield 0.35%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, PerkinElmer Inc ranks 10 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate PerkinElmer Inc.

Growth B / 168
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 190.2% 5 year annualized EPS growth, 1.9% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 3.4% combine to produce this average score.

PerkinElmer Inc (PKI)
Healthcare | Health Services
78.90  1.64%


tickrz rank
B
VALUATION RATIOS
P/E Ratio21.97x
P/B Ratio3.45x
P/S Ratio4.01x
EV/EBITDA Ratio21.21x
DIVIDEND ANALYSIS
DIVIDEND YIELD
0.35%
PAYOUT RATIO7.71%
3 YR DIVIDEND GROWTH0%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
7 OUT OF 9
DEBT-TO-EQUITY44%
INTEREST COVERAGE7.9x
CURRENT RATIO2.59
MOAT
ROE17.07%
ROIC8.82%
Net Margin10.2%
GROWTH
5 YR EPS GROWTH190.15%
5 YR SPS GROWTH1.94%
5 YR BPS GROWTH3.38%

TICKRZ RANK
PerkinElmer Inc receives a B ranking in our multi-factor model that blends valuation, moat, operational performance, and financial strength. View the tickrz MFM Screener here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. PerkinElmer Inc's valuation score is comprised of a P/E ratio of 22x, a P/B ratio of 3.5x, a P/S ratio of 4x, and an EV/EBITDA ratio of 21.2x. PerkinElmer Inc ranks 309 out of the S&P 500 constituents on valuation--a relatively weak score.

WARREN BUFFETT RANKING
PerkinElmer Inc ranks 166 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a average score, meaning it ranks in the middle of the pack on valuation, moat, volatility, and financial strength factors. The stock's average Buffett rank suggests waiting for improved valuation or quality metrics before taking action. The company's moat is strong so it could be worth investigating in the future should its valuation improve.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is strong. PerkinElmer Inc appears to have a durable competitive advantage within the Healthcare sector.

FINANCIAL STRENGTH
PerkinElmer Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 7.9x, a debt/equity ratio of 44% and a Moat Rank of 44 translate to a strong Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 34.29% over the last 12 months. This performance is strong compared to other stocks in the S&P 500, earning it a rank of 99. PerkinElmer Inc's strong 12 month stock performance will appeal to momentum investors.

VALUE + YIELD
Shares currently yield 0.35%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, PerkinElmer Inc ranks 10 among the S&P 500 constituents. Investors looking for undervalued dividend stocks will want to closely investigate PerkinElmer Inc.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value produce an average score. 190.2% 5 year annualized EPS growth, 1.9% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 3.4% combine to produce this average score.